Merck & Co., Inc. (MRK)
NYSE: MRK · Real-Time Price · USD
150.33
-2.01 (-1.32%)
At close: Sep 4, 2026, 4:00 PM EDT
150.99
+0.66 (0.44%)
After-hours: Sep 4, 2026, 7:38 PM EDT
Merck & Co. Employees
Merck & Co. had 75,000 employees as of December 31, 2025. The number of employees did not change compared to the previous year.
Employees
75,000
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$887,587
Profits / Employee
$42,307
Market Cap
370.89B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 75,000 | 0 | - |
| Dec 31, 2024 | 75,000 | 3,000 | 4.17% |
| Dec 31, 2023 | 72,000 | 3,000 | 4.35% |
| Dec 31, 2022 | 69,000 | 1,000 | 1.47% |
| Dec 31, 2021 | 68,000 | -6,000 | -8.11% |
| Dec 31, 2020 | 74,000 | 3,000 | 4.23% |
| Dec 31, 2019 | 71,000 | 2,000 | 2.90% |
| Dec 31, 2018 | 69,000 | 0 | - |
| Dec 31, 2017 | 69,000 | 1,000 | 1.47% |
| Dec 31, 2016 | 68,000 | 0 | - |
| Dec 31, 2015 | 68,000 | -2,000 | -2.86% |
| Dec 31, 2014 | 70,000 | -6,000 | -7.89% |
| Dec 31, 2013 | 76,000 | -7,000 | -8.43% |
| Dec 31, 2012 | 83,000 | -3,000 | -3.49% |
| Dec 31, 2011 | 86,000 | -8,000 | -8.51% |
| Dec 31, 2010 | 94,000 | -6,000 | -6.00% |
| Dec 31, 2009 | 100,000 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Johnson & Johnson | 138,200 |
| AstraZeneca | 95,100 |
| Novartis AG | 75,267 |
| Pfizer | 75,000 |
| Sanofi | 74,846 |
| Novo Nordisk | 69,505 |
| AbbVie | 57,000 |
| Eli Lilly and Company | 50,000 |
MRK News
- 13 hours ago - Merck price target raised to $170 from $150 at Wells Fargo - TheFly
- 1 day ago - India's Cipla, China's Qilu partner for US launch of Merck's Keytruda biosimilar - Reuters
- 2 days ago - Why Moderna's Cancer Vaccine Matters to Investors - ETF Trends
- 2 days ago - Merck to Participate in the Wells Fargo 21st Annual Healthcare Conference - Business Wire
- 7 days ago - Success after a century of failures: Inside Moderna and Merck's cancer vaccine breakthrough - Reuters
- 10 days ago - Explainer: How the Merck/Moderna cancer vaccine works and possible barriers to wide use - Reuters
- 10 days ago - What Happens if Moderna's Cancer Vaccine Works - Barrons
- 10 days ago - Merck price target raised to $170 from $145 at Argus - TheFly